Darolutamide in the Treatment of Non-Metastatic Castration Resistant Prostate Cancer

In an effort to promote higher quality patient care NCODA created the NCODA Positive Quality Intervention (PQI) as a peer-reviewed clinical guidance document for healthcare providers. By providing Quality Standards and effective practices around a specific aspect of cancer care, PQIs equip the entire multidisciplinary care team with a sophisticated yet concise resource for managing patients receiving oral or IV oncolytics. This PQI in Action is a follow up to the Darolutamide (NUBEQA®) In the Treatment of Non-Metastatic Castration Resistant Prostate Cancer PQI and explores how the medically integrated teams at Chesapeake Urology, a member of the United Urology Group and The Urology Group incorporate PQI’s as part of their daily workflow. It will discuss how utilizing the Darolutamide (NUBEQA®) In the Treatment of Non-Metastatic Castration Resistant Prostate Cancer PQI elevates patient care.